secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tenon Medical, Inc. (TNON)
CIK:        0001560293
Form:       8-K
Filed at:   2026-03-19T23:59:59+00:00
Accession:  0001213900-26-031840
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tenon Medical Q4 revenue $1.5M (+92% YoY); full year $3.9M (+20%); FDA clearance for next-gen SI fusion system
--------------------------------------------------------------------------------

- Q4 revenue $1.5M (+92% YoY); gross margin improved to 69% from 46%.
- Full year 2025 revenue $3.9M (+20% YoY); gross margin 60%, up from 52%.
- Net loss improved: Q4 loss $2.8M ($0.29/sh) vs $3.1M ($0.98/sh); full year loss $12.6M ($1.70/sh) vs $13.7M ($11.26/sh).
- Received FDA 510(k) clearance for SImmetry+ SI Joint Fusion System, expanding to lateral approach.
- Closed $4.3M convertible note offering in March 2026; cash $3.8M at year-end, no debt.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1560293/000121390026031840/0001213900-26-031840-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1560293/000121390026031840/ea0282552-8k_tenon.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-031840

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer